Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Breaking News: Medtronic stops sales & distribution of HVAD system due to multiple issues

News You Need to Know Today
Breaking News: Medtronic stops sales & distribution of HVAD system due to multiple issues
Thursday, June 3, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Breaking News

Medtronic stops sales and distribution of HVAD system due to multiple issues, including 14 patient deaths

The device's internal pump was associated with a heightened risk of adverse outcomes, including stroke and death. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Medtronic stops sales and distribution of HVAD system due to multiple issues, including 14 patient deaths

Share on Twitter Share on Facebook Share on Linkedin
The device's internal pump was associated with a heightened risk of adverse outcomes, including stroke and death. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

CPT code updates | Pope meets with cardiologists | Philips makes a move | ASC growth | Catheters recalled | Workforce woes
RDN reimbursement | Cardiologist's victims file lawsuit | First-in-human heart surgery | Societies must adapt | TAVR or SAVR?
Cardiologist's actions at heart of new lawsuit against online dating apps
CMS considers covering TAVR in asymptomatic patients | Cardiologist dies after arrest | The risks of various cancer treatments
News Alert: CMS considers covering TAVR in asymptomatic patients
Key reimbursement updates | Philips to acquire SpectraWAVE | New CCTA software from Siemens Healthineers
Philips to acquire imaging company | FDA approves nasal spray for heart patients | New device makes debut | AS in women vs. men

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …34
    • Page 35
    • Page 36
    • Page 37
    • Current page 38
    • Page 39
    • Page 40
    • Page 41
    • Page 42 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme